MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$146,268K
(11.63%↑ Y/Y)
Foreign currency
translation adjustment
$144K
(105.42%↑ Y/Y)
Net loss
-$146,412K
(10.10%↑ Y/Y)
Income tax recovery
-$31,183K
(16.93%↑ Y/Y)
Interest income
$28,329K
(-26.37%↓ Y/Y)
Grants and incentives
$13,890K
(1.98%↑ Y/Y)
Loss before income
tax
-$177,595K
(11.38%↑ Y/Y)
Total other income
$39,508K
(-65.46%↓ Y/Y)
License
$46,920K
Research Fees
$27,208K
Milestone Payments
$1,000K
Other (note 15)
-$2,711K
(-104.35%↓ Y/Y)
Loss from operations
-$217,103K
(31.03%↑ Y/Y)
Total revenue
$75,128K
(185.83%↑ Y/Y)
Total operating
expenses
$292,231K
(-14.95%↓ Y/Y)
Research and development
$186,829K
(11.70%↑ Y/Y)
Sales, general and
administrative
$83,231K
(14.47%↑ Y/Y)
Depreciation, amortization,
and impairment
$22,171K
(-75.60%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)